Literature DB >> 32455904

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice. Brain Sci. 2020, 10, 176.

Javier Pagonabarraga1,2,3, José Matías Arbelo4,5, Francisco Grandas6,7, Maria-Rosario Luquin8,9, Pablo Martínez Martín10,11, Maria Cruz Rodriguez-Oroz12,13, Francesc Valldeoriola14,15, Jaime Kulisevsky1,2,3,16,17.   

Abstract

We would like to submit the following erratum to our recently published paper [...].

Entities:  

Year:  2020        PMID： 32455904      PMCID： PMC7288153          DOI： 10.3390/brainsci10050313

Source DB:  PubMed          Journal:  Brain Sci        ISSN： 2076-3425


We would like to submit the following erratum to our recently published paper [1] due to the errors in the abstract. We request (1) the removal of the word “motor” from the first line of the abstract, so that the sentence reads: “Safinamide is an approved drug for the treatment of fluctuations in Parkinson’s disease (PD)”, and (2) that the word “OFF” is changed to “ON” in line 6 of the abstract, so that the sentence reads: “Safinamide significantly improves the mean daily ON time without troublesome dyskinesias.” We apologize for any inconvenience caused to our readers.
  1 in total

Review 1.  A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice.

Authors:  Javier Pagonabarraga; José Matías Arbelo; Francisco Grandas; Maria-Rosario Luquin; Pablo Martínez Martín; Mari Cruz Rodríguez-Oroz; Francesc Valldeoriola; Jaime Kulisevsky
Journal:  Brain Sci       Date:  2020-03-18
  1 in total
  1 in total

Review 1.  Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

Authors:  Yu-Yan Tan; Peter Jenner; Sheng-Di Chen
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.